Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI Study of D352 and D794 in Healthy Volunteers
NCT06758661Phase 1Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Nov 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in dyslipidemia comparing D352 Sequence with D794 Sequence (2 arms). Primary endpoints: Area Under the Concentration-Time Curve over the Dosing Interval at Steady State for D352 at Day 21, Area Under the Concentration-Time Curve over the Dosing Interval at Steady State for D794 at Day 21 and 2 more. Started Nov 2024; status: completed.
02
Drugs
D352omega-3-acid ethyl esters
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06758661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06758661.